No Detail Found!

In-Silico Identification of Natural Nucleotide Metabolites as Potential Inhibitors Targeting Chikungunya nsP3 for Antiviral Therapy

Author(s)
Sana Shamim Department of Pharmaceutical Chemistry, Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Ojha Campus, Karachi, Pakistan.
Samina Baig Dow Institute of Medical Technology, Dow University of Health Sciences, Karachi, Pakistan.
Sawera Shaukat Dow Institute of Medical Technology, Dow University of Health Sciences, Karachi, Pakistan.
Bushra Asghar Dow Institute of Medical Technology, Dow University of Health Sciences, Karachi, Pakistan.
Irma Nadeem Dow Institute of Medical Technology, Dow University of Health Sciences, Karachi, Pakistan.
Abstract
Background: Recent re-emergence of Chikungunya, an RNA viral belonging to the alphavirus genus within the Togaviridae family is critical for management. The disease spread by mosquitoes especially Aedesaegypti and Aedes Albopictus species, causative for dengue and Zikaviruse. Currently, the scenario gets worsens, as there is no specific antiviral medication or vaccination available for treating CHIKV infection. Aims and Objective: Therefore, herein we apply an In-silico approach to discover and identify the natural compounds having potential as anti-CHIKV agent, by preventing time and economic burden involving the drug discovery process and toxicities related to synthetic chemical compounds. Methodology: This research utilized Auto Dock vina software to assess the binding interactions between the CHIKV protein (PDB ID: 3GPO) and the ligand ARP ribose. The ARP ribose is used as lead compound for the screening of natural product databases by applying structural similarity methodology. The docking analysis identified the active site of the CHIKV protein and highlighted essential residues involved in ligand binding by virtual screening of the compounds along with their ADME and Toxicity studies by Swiss ADME and protox-II webserver. Results: Among all these compounds, selected 07 compounds were screened, among which CNP0001913 and CNP0219461 exhibits the binding affinities of -8.00 and -7.7 kcal/mol, identifying them as potential anti-CHIKV agents of natural origin. Conclusion: On the basis of ADMET studies and molecular interaction of studied structural similar compounds of Adenosine-5-diphosphoribose (ADPR), nucleotide metabolite involved in activation of TRPM2 ion channel, controlling multiple cellular processes, pathogenesis and replication of the non-structural protein 3(nsp3) of CHIKV interacting with macrodomain essential for viral virulence. All the screened molecules exhibits more binding affinity then ADPR but CNP0001913 and CNP0219461 exhibits more affinity and involves more hydrogen bonding then other molecules. Further assurance by in-vitro studies is required.
Publication Details
Page(s) 112-122
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 3, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Insilico, toxicity, ADME, Docking, Chikungunya
References
Mourad O,Makhani L,Chen LH . .Chikungunya: An Emerging Public Health Concern. Curr Infect Dis Rep, 24(12) : 217-28.
Christofferson RC,Turner EA,Peña-García VH .2023 .Identifying knowledge gaps through the systematic review of temperature-driven variability in the competence of Aedes aegypti and Ae. albopictus for chikungunya virus. Pathogens, 12(11) : 1368.
Ribeiro dos Santos G,Jawed F,Mukandavire C,Deol A,Scarponi D,Mboera LE .2024 .The global burden of chikungunya virus and the potential benefit of vaccines. , : 2024-10.
Khongwichit S,Chansaenroj J,Chirathaworn C,Poovorawan Y. .2021 .Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries. J Biomed Sci, 28(1) : 84.
Ammar M,Moaaz M,Yue C,Fang Y,Zhang Y,Shen S .2025 .. Emerging Arboviral Diseases in Pakistan: Epidemiology and Public Health Implications. Viruses, 17(2) : 232.
India TRC .2021 .TRC) for CV in. Current status of Chikungunya in India. , 12 : 695173.
Hasan A,Zamil MF,Trina AT,Hossain MS,Afreen S,Ahmed D .2024 .Chikungunya's return amidst 2024 dengue season: Implications for future outbreaks in Bangladesh. , : 2024-12.
Tun MMN,Mutua MM,Inoue S,Takamatsu Y,Kaneko S,Urano T .2025 .Molecular and Serological Evidence of Chikungunya Virus Among Dengue Suspected Patients in Sri Lanka. Journal of Infection and Public Health, 102709 : .
de Lima Cavalcanti TYV,Pereira MR,de Paula SO,Franca RF de O. SO .2022 .A review on chikungunya virus epidemiology, pathogenesis and current vaccine development. Viruses, 14(5) : 969.
Sofyantoro F,Frediansyah A,Priyono DS,Putri WA,Septriani NI,Wijayanti N . .Growth in chikungunya virus-related research in ASEAN and South Asian countries from 1967 to 2022 following disease emergence: a bibliometric and graphical analysis. Global Health. 2023 Feb, 6(1) : 9.
Badar N,Ikram A,Salman M,Alam MM,Umair M,Arshad Y .2021 .Epidemiology of Chikungunya virus isolates 2016-2018 in Pakistan. Journal of Medical Virology, 93(11) : 6124-31.
Bellone R,Failloux AB .2020 .The role of temperature in shaping mosquito-borne viruses transmission. Frontiers in Microbiology, 11 : 584846.
Yadav N,Upadhyay RK,Seasonal-CyclesVector-Population- RK . .-Rising-Challenges-of-Communicable-Diseases-A.pdf. 2023 [cited 2025 Mar, 6(1) : .
Delrieu M,Martinet JP,O'connor O,Viennet E,Menkes C,Burtet-Sarramegna V,Vector-Borne Diseases V .2023 .Temperature and transmission of chikungunya, dengue, and Zika viruses: A systematic review of experimental studies on Aedes aegypti and Aedes albopictus. , 4 : 100139.
Näslund J,Ahlm C,Islam K,Evander M,Bucht G,Lwande OW,Strategies Preventive,Diseases Zoonotic . .Emerging Mosquito-Borne Viruses Linked to Aedes aegypti and Aedes albopictus : Global Status. 2021 Oct, 1(10) : 731-46.
Anoopkumar AN,Aneesh EM . .A critical assessment of mosquito control and the influence of climate change on mosquito-borne disease epidemics. Environ Dev Sustain, 24(6) : 8900-29.
Tan YB,Chmielewski D,Law MCY,Zhang K,He Y,Chen M . .Molecular architecture of the Chikungunya virus replication complex. 2022 Dec, 2(48) : eadd2536.
Laurent T,Kumar P,Liese S,Zare F,Jonasson M,Carlson A .2022 .Architecture of the chikungunya virus replication organelle. Elife, 11 : e83042.
Sun K. . .A novel interaction between the 5′ untranslated region of the virus genome and Musashi homolog 2 is essential for Chikungunya virus genome replication. 2022 [cited 2025 Mar, 13 : .
Kovacikova K,Van Hemert MJ K . .Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance. Antimicrob Agents Chemother. 2020 Nov, 64(12) : e01788-20.
Shimizu JF,Martins DOS,McPhillie MJ,Roberts GC,Zothner C,Merits A .2020 .Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches? Acta tropica. , 207 : 105490.
Dominguez F,Shiliaev N,Lukash T,Agback P,Palchevska O,Gould JR . .NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation. López S, editor. 2021 Jul, 95(16) : e00836-21.
Hucke FIL,Bestehorn-Willmann M,Bugert JJ .2021 .Prophylactic strategies to control chikungunya virus infection. Virus Genes, 57(2) : 133-50.
Chandrakanta ,Prajapati BG,Sah AN,Amponsah SK,Shegokar R,Pathak YV . .Chikungunya Fever: Epidemiology, Clinical Manifestation, and Management. Rising Contagious Diseases [Internet]. 1st ed. Wiley; 2024 [cited 2025 Mar, 13 : 181-98.
Zhang Y,Yan H,Li X,Zhou D,Zhong M,Yang J .2022 .A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus. PLoS Neglected Tropical Diseases, 16(1) : e0010149.
Singh A,Kumar A,Yadav R,Uversky VN,Giri R .2018 .Deciphering the dark proteome of Chikungunya virus. Scientific reports, 8(1) : 5822.
Miller LM,Draper BE,Jarrold MF . .Charge Detection Mass Spectrometry Reveals Norovirus GII.4 Virus-like Particles Failure to Complete. 2025 Jul, 15 : jasms.
Mangala Prasad V,Blijleven JS,Smit JM,Lee KK JM .2022 .Visualization of conformational changes and membrane remodeling leading to genome delivery by viral class-II fusion machinery. Nature Communications, 13(1) : 4772.
Malet H,Coutard B,Jamal S,Dutartre H,Papageorgiou N,Neuvonen M .2009 .The Crystal Structures of Chikungunya and Venezuelan Equine Encephalitis Virus nsP3 Macro Domains Define a Conserved Adenosine Binding Pocket. J Virol, 83(13) : 6534-45.
Kim S,Chen J,Cheng T,Gindulyte A,He J,He S .2025 .PubChem 2025 update. Nucleic acids research, 53(D1) : D1516-25.
Banerjee P,Kemmler E,Dunkel M,Preissner R. .2024 .ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 52(W1) : W513-20.
Biovia DS .2019 .. [accessed 2023 July, 23 : .
Morris GM,Huey R,Lindstrom W,Sanner MF,Belew RK,Goodsell DS .2009 .AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem, 30(16) : 2785-91.
Sorokina M,Merseburger P,Rajan K,Yirik MA,Steinbeck C. .2021 .COCONUT online: Collection of Open Natural Products database. J Cheminform, 13(1) : 2.
Halder SK,Sultana I,Shuvo MN,Shil A,Himel MK,Hasan MdA . .In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS‐CoV‐2: A Molecular Docking and Dynamics Simulation Approach. BioMed Research International. 2023 Jan;2023, (1 : 5469258.
Kumar D,Meena MK,Kumari K,Patel R,Jayaraj A,Singh P. . .In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation. 2020 [cited 2025 Jul, 8440(20) : 31563-2.
0

Citations

0

Downloads

17

Views